Solvay's Stock Breaks Through Its Resistance at €28.56 Ahead of May 7th Results
The Belgian chemical company advances to €28.56 at midday, three sessions before its Q1 2026 earnings release. The stock is moving against the trend of the CAC 40, which is down by 0.53% during the session. Over three months, the increase reaches 11.82%, but the annual performance remains negative at -15.8%.
The stock price is exactly at the identified resistance threshold of €28.56, after a week up by 3.86%. It also exceeds the upper limit of the Bollinger Bands set at €28.46, indicating a short-term overbought configuration. However, the RSI at 53 remains neutral, reflecting a bullish momentum without significant excess in the medium term. The 50-day and 200-day moving averages, at €26.85 and €27.26 respectively, have now been surpassed from above. This setup extends the movement that began in early April, when Solvay had already exceeded its Bollinger Bands at €28.32.
Quarterly Earnings Release in Three Days, Amidst Oil at $108 a Barrel
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The group will publish its Q1 2026 results on Thursday, May 7th, marking the first financial event since the annual communication at the end of February. Solvay's stock is operating in a tense energy environment: Brent crude is trading around $108 per barrel, fueled by tensions in the Strait of Hormuz. For a chemical industry player, the cost of energy remains a direct parameter affecting margins. Additionally, the ECB kept its key interest rates unchanged on April 30th, highlighting increased risks on inflation and growth. The annual general meeting will be held on May 12th, five days after the quarterly publication.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.